NASATAPP Phenylpropanolamine Hydrochloride / Brompheniramine Maleate 12.5mg / 4mg per 5mL Syrup 60mL
RXDRUG-DR-XY24309
Discreet Packaging
We recognize that purchasing medications can be a deeply personal matter. To respect your privacy, we ensure that all orders are packaged discreetly, with no indication of the contents on the packaging. This means that even our couriers remain unaware of the package contents.
Furthermore, we uphold strict confidentiality standards. We guarantee that your order information will never be disclosed to any third party. Your trust is paramount to us, and we are committed to safeguarding your privacy at every step of the process. Our dedication to discretion and confidentiality is part of our unwavering commitment to you, our valued customer.
FDA-registered Products
FDA-licensed Pharmacies
Features
Brand
Nasatapp
Full Details
Dosage Strength
12.5mg / 4mg per 5ml
Drug Ingredients
- Brompheniramine Maleate
- Phenylpropanolamine
Drug Packaging
Syrup 60ml
Generic Name
Phenylpropanolamine Hydrochloride / Brompheniramine Maleate
Dosage Form
Syrup
Registration Number
DR-XY24309
Drug Classification
Prescription Drug (RX)
Description
Indications/Uses
Indicated for allergic and vasomotor or other hyperactive nasal disorders and acute coryza, relief of nasal congestion and hypersecretion. Relief of nasal congestion in infants up to children 12 years of age.
Dosage/Direction for Use
Tablet: 1 tablet twice a day.
Syrup: Adult: 1-2 tsp (5-10 mL) to be given every 6-8 hrs.
Children 5-12 years: 1 tsp (5 mL); 3-4 years: ¾ tsp (3.75 mL); 7 months to 2 years: ½ tsp (2.5 mL); 1-6 months: ¼ tsp (1.25 mL).
Drops: Infants 7 months to 2 years: 1 mL; Up to 6 months: 0.5 mL.
Syrup: Adult: 1-2 tsp (5-10 mL) to be given every 6-8 hrs.
Children 5-12 years: 1 tsp (5 mL); 3-4 years: ¾ tsp (3.75 mL); 7 months to 2 years: ½ tsp (2.5 mL); 1-6 months: ¼ tsp (1.25 mL).
Drops: Infants 7 months to 2 years: 1 mL; Up to 6 months: 0.5 mL.
Administration
May be taken with or without food: May be taken w/ food or milk to reduce GI discomfort.
Contraindications
Brompheniramine is contraindicated in patients with known brain damage or epilepsy.
Warnings
Care is necessary if phenylpropanolamine (PPA) is to be given to patients with high blood pressure, toxic goiter, benign prostatic hypertrophy, heart rate irregularity, glaucoma and to those receiving antidepressant therapy. Patients with heart disease and uncontrolled or untreated high blood pressure should consult a doctor prior to taking PPA.
Tablet: Nasatapp tablet contains tartrazine (FD&C yellow No. 5) which may cause allergic reaction including bronchial asthma in certain susceptible person.
Tablet: Nasatapp tablet contains tartrazine (FD&C yellow No. 5) which may cause allergic reaction including bronchial asthma in certain susceptible person.
Special Precautions
Phenylpropanolamine HCl: Sympathomimetic agents should be used with caution in patients which may be particularly susceptible to their effects, particularly those with hyperthyroidism. Great care is also needed in patients with cardiovascular disease eg, ischemic heart disease, arrhythmia or tachycardia, occlusive vascular disorders eg, arteriosclerosis, hypertension or aneurysms. Anginal pain may be precipitated in patients with angina pectoris.
Excessive administration of sympathomimetic agents to the nasal mucosa may produce rebound congestion and rhinorrhea. Care is also required when sympathomimetic agents are given to patients with diabetes mellitus or closed-angle glaucoma.
Brompheniramine Maleate: Antihistamine should not be given to premature infants or neonates. This group of patients has an increased susceptibility to antimuscarinic effects. Elderly patients are also more susceptible to many adverse effects of antihistamines including antimuscarinic effects, sedation and hypotension.
Because of their antimuscarinic properties, antihistamines should be used with care in conditions eg, closed-angle glaucoma, urinary retention, prostatic hypertrophy, or pyloroduodenal obstruction.
Effects on the Ability to Drive or Operate Machinery: Brompheniramine Maleate: Many antihistamines may cause drowsiness, so patients affected should not drive or operate machinery. Patients should avoid alcoholic drink.
Excessive administration of sympathomimetic agents to the nasal mucosa may produce rebound congestion and rhinorrhea. Care is also required when sympathomimetic agents are given to patients with diabetes mellitus or closed-angle glaucoma.
Brompheniramine Maleate: Antihistamine should not be given to premature infants or neonates. This group of patients has an increased susceptibility to antimuscarinic effects. Elderly patients are also more susceptible to many adverse effects of antihistamines including antimuscarinic effects, sedation and hypotension.
Because of their antimuscarinic properties, antihistamines should be used with care in conditions eg, closed-angle glaucoma, urinary retention, prostatic hypertrophy, or pyloroduodenal obstruction.
Effects on the Ability to Drive or Operate Machinery: Brompheniramine Maleate: Many antihistamines may cause drowsiness, so patients affected should not drive or operate machinery. Patients should avoid alcoholic drink.
Adverse Reactions
Brompheniramine maleate: Antimuscarinic effects, sedation, hypotension.
Drug Interactions
Actions prolonged by monoamine oxidase inhibitors (MAOIs). Potentiate effects of other CNS depressants.
Storage
Store at temperatures not exceeding 30°C.
MedsGo Class
Cough & Cold Preparations
Please sign in so that we can notify you about a reply